According to a recent LinkedIn post from Osmind, the company is promoting monthly SPRAVATO office hours targeted at clinicians and practice teams. The session scheduled for May 5 focuses on lowering SPRAVATO drug costs and improving practice operations via expert and peer guidance.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The LinkedIn post highlights topics including leveraging community benefits to reduce SPRAVATO-related expenses, onboarding and setup support, and practice management best practices. For investors, this suggests Osmind is deepening its role as an operational and reimbursement partner in psychiatry, which could enhance customer retention and recurring platform usage.
The post also references live Q&A components, indicating an emphasis on ongoing engagement with providers rather than one-time training. If these sessions help clinics navigate cost and workflow barriers around SPRAVATO, Osmind may strengthen its position in the growing interventional psychiatry segment and potentially widen its addressable market within mental health practices.